Evaluation of Lipiodol in transcatheter arterial embolization for primary hepatocellular carcinoma. Analysis by Cox's proportional hazard model.
-
- KAMINO Keiji
- Department of Radiology, Hyogo College of Medicine
-
- NAKAO Norio
- Department of Radiology, Hyogo College of Medicine
-
- OHNISHI Mitsunori
- Department of Radiology, Hyogo College of Medicine
-
- MIURA Kohi
- Department of Radiology, Hyogo College of Medicine
-
- MIURA Takashi
- Department of Radiology, Hyogo College of Medicine
Bibliographic Information
- Other Title
-
- 原発性肝細胞癌TAEにおけるリピオドールの有用性 Coxの比例ハザードモデルによる検討
- Analysis by Cox's proportional hazard model
- Coxの比例ハザードモデルによる検討
Search this article
Abstract
Using the Cox's proportional hazard model, we retrospectively and statistically analyzed 120 cases of primary hepatocellular carcinoma treated with transcatheter arterial embolization during the period from 1984 to 1989 to define the usefullness of LipiodolTM (LP) in TAE. The cases were divided into Gelfoam Sponge (GS) group (49 cases) and GS+LP group (75 cases) according to the embolic material used. The analysis by Cox's proportional hazard model revealed that the corrected survival rate for the GS group was 59.1% at 1 year and 25.1% at 2 years whereas the rate for GS+LP group was 80.8% at 1 year, 61.1% at 2 years, and 17.5% at 3 years, suggesting favorable effect of the concomitant use of LP on the prognosis of hepatocellular carcinoma. The risk ratio of TAE without LP to that with LP was 1.624.
Journal
-
- Kanzo
-
Kanzo 31 (10), 1186-1190, 1990
The Japan Society of Hepatology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679766821760
-
- NII Article ID
- 130000878444
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed